GAS5 and nasopharyngeal carcinoma: In light of the aforementioned evidence, it would be plausible to suggest that GAS5 acts as a ceRNA of miR-17-3p, thereby contributing to ECM degradation and NPC apoptosis, while targeting GAS5 or elevating miR-17-3p may contribute to the development of new therapeutic strategies for IVDD.